|

BL-M24D1 Clinical Trials

4 actively recruiting trials

▲ +1 trial since June 2026

Pipeline

Phase 1: 4

Top Sponsors

  • Sichuan Baili Pharmaceutical Co., Ltd.4

Indications

  • Cancer4
  • Solid Tumor2
  • Solid Tumors1
  • Hematologic Malignancies1
  • Gastrointestinal Tumors1

Other4 trials

A Study of BL-M24D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors
Phase 1
A Study of BL-M24D1 in Patients With Locally Advanced or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
Phase 1
A Study of BL-M24D1 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer and Other Solid Tumors
Phase 1
A Study of BL-M24D1 in Patients With Relapsed or Refractory Multiple Myeloma and Other Hematologic Malignancies
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.